Pu Sheng-Lan, Zhang Xiang-Yan, Liu Dai-Shun, Ye Ba-Ning, Li Jian-Quan
Department of General Medicine, The First People's Hospital of Zunyi, Zunyi 563000, Guizhou Province, China.
Respiratory Institute, Guizhou Provincial People's Hospital, Guiyang 550000, Guizhou Province, China.
World J Clin Cases. 2021 Feb 26;9(6):1394-1401. doi: 10.12998/wjcc.v9.i6.1394.
A disease caused by a novel coronavirus virus, named coronavirus disease 2019 (COVID-19), broke out in Wuhan, China in December 2019, and spread around the word. As of March 4, 2020, 93090 confirmed cases and 2984 deaths have been reported in more than 80 countries and territories. It has triggered global public health security. However, the features and prognosis of COVID-19 are incompletely understood.
We here report that the erythrocyte sedimentation rate (ESR) increased in a confirmed COVID patient. The high level of ESR sustained for a long time even after the patient recovered from COVID-19, while all results related to tumor, tuberculosis, rheumatic diseases, anemia, cannot explain the abnormal elevation of ESR presented in this case.
Although the increased ESR cannot be explained by all existing evidence, it possibly links the abnormal pathologic change in some COVID-19 patients and negative prognosis, and provides the clue to dissect the mechanism of illness progressing in COVID-19 and its prognosis.
2019年12月,一种由新型冠状病毒引起的疾病——2019冠状病毒病(COVID-19)在中国武汉爆发,并在全球范围内传播。截至2020年3月4日,80多个国家和地区报告了93090例确诊病例和2984例死亡病例。它引发了全球公共卫生安全问题。然而,人们对COVID-19的特征和预后了解并不完全。
我们在此报告一名确诊的COVID患者红细胞沉降率(ESR)升高。即使该患者从COVID-19中康复后,ESR的高水平仍持续了很长时间,而所有与肿瘤、结核、风湿性疾病、贫血相关的检查结果均无法解释该病例中ESR的异常升高。
尽管现有所有证据均无法解释ESR升高的原因,但它可能与一些COVID-19患者的异常病理变化及不良预后相关,并为剖析COVID-19疾病进展机制及其预后提供了线索。